Preclinical
Tom Parry, PhD, MBA, BCMAS—Founder
Tom Parry, PhD, MBA, BCMAS—Founder
Tom Parry, PhD, MBA, BCMAS—Founder
Pharmacology (nonclinical and clinical), Nonclinical Safety (toxicology, safety pharmacology), Pharmacokinetics/ADME, Medical Affairs, Regulatory Writing
Donald Button, PhD
Tom Parry, PhD, MBA, BCMAS—Founder
Tom Parry, PhD, MBA, BCMAS—Founder
Pharmacology, Bioanalytical, Biochemical and Cell Based Assays, Regulatory Writing
Angela Lynch, PhD, MSPH, DABT
Tom Parry, PhD, MBA, BCMAS—Founder
Angela Lynch, PhD, MSPH, DABT
Yusuf El-Sherif
Harshini Neelakantan, Ph.D.
Angela Lynch, PhD, MSPH, DABT
GLP Study Direction, Toxicology and Safety Assessment, Regulatory Compliance, Quality Systems, Scientific Writing, Botanical and Natural Product Sciences
Harshini Neelakantan, Ph.D.
Harshini Neelakantan, Ph.D.
Harshini Neelakantan, Ph.D.
Nonclinical Drug Development Strategy, Small Molecule Development (IND-Enabling), Asset Evaluation and Prioritization, Investor and KOL Communication
Clinical
Andrew Eisen, MD, PhD
Andrew Eisen, MD, PhD
Andrew Eisen, MD, PhD
Translational Medicine and Clinical Development, Clinical Trials (FIH to POC), Pediatrics, Clinical and Molecular Genetics, Omics Research
Marilyn Dar, MBA, PMP
Andrew Eisen, MD, PhD
Andrew Eisen, MD, PhD
Program Management, Clinical Operations and Clinical Project Management
CMC and Quality
Craig Hacket, PhD
Kallol Biswas, PhD
Kallol Biswas, PhD
Process & Analytical Development, Clinical Manufacturing & Supply, CMO Management, Regulatory Filings
Kallol Biswas, PhD
Kallol Biswas, PhD
Kallol Biswas, PhD
CMC Strategy and Execution, IND-Enabling Development, Regulatory Planning and FDA Interactions, Analytical Development, CDMO and Tech Transfer, Program Leadership
Paula Miller, PhD
Paula Miller, PhD
Paula Miller, PhD
Small and Large Molecule CMC and Program Management, Regulatory and GMP Management
Bonnie Pappacena
Paula Miller, PhD
Paula Miller, PhD
Quality Assurance and Compliance, GCP/GLP/GMP, Drug Product and Combination Product Development, Quality Program Development, Regulatory Affairs, Pharmacovigilance (GPV)
Medical Affairs
Tom Parry, PhD, MBA, BCMAS—Founder
Tom Parry, PhD, MBA, BCMAS—Founder
Tom Parry, PhD, MBA, BCMAS—Founder
Pharmacology (nonclinical and clinical), Nonclinical Safety (toxicology, safety pharmacology), Pharmacokinetics/ADME, Medical Affairs, Regulatory Writing
Leslie Leahy, PhD
Tom Parry, PhD, MBA, BCMAS—Founder
Tom Parry, PhD, MBA, BCMAS—Founder
Global medical and clinical drug development, CNS drug strategy (Phase I–IV), launch readiness, BD&L, competitive intelligence, pharmacoeconomics
Linda Console-Bram, PhD, BCMAS
Tom Parry, PhD, MBA, BCMAS—Founder
Linda Console-Bram, PhD, BCMAS
Legal, Intellectual Property & Finance
Veronica Go-Stevens, PhD,
Veronica Go-Stevens, PhD,
Veronica Go-Stevens, PhD,
Registered Patent Agent, Technology Licensing, Business Development and Strategic Partnerships, Patent Law, Scientific Asset Evaluation, Market Analysis, Commercialization Strategy
Mark Dellaporta, Esq
Veronica Go-Stevens, PhD,
Veronica Go-Stevens, PhD,
Licensing and Technology Agreements, Manufacturing and Supply Contracts, Clinical Development Agreements, Regulatory Compliance, GMP/GCP, FCPA
Roberto Pastrano
Veronica Go-Stevens, PhD,
Roberto Pastrano
Corporate accounting, financial analysis, budgeting and forecasting, finance and operations leadership, biotech/life sciences, business development, bilingual (English/Spanish)